Tatlisumak T, Takano K, Carano R A, Fisher M
Department of Neurology, Helsinki University Central Hospital, Finland.
Stroke. 1996 Dec;27(12):2292-7; discussion 2298. doi: 10.1161/01.str.27.12.2292.
Basic fibroblast growth factor (bFGF) has documented neuroprotective properties. This study was performed to evaluate the effects of bFGF on infarct size when administered 30 minutes after induction of focal cerebral ischemia in rats. Diffusion-weighted and perfusion MRI were used during the drug infusion.
We blindly randomized 20 Sprague-Dawley rats to receive either drug (n = 10) or vehicle (n = 10). The animals underwent middle cerebral artery (MCA) occlusion using the suture model. Diffusion-weighted MRI was initiated 30 minutes after induction of ischemia and repeated frequently for 3.5 hours. Drug (45 micrograms/kg per hour) or vehicle (saline) infusion began 30 minutes after MCA occlusion and continued for 3 hours. Perfusion images were made at 25, 90, and 150 minutes after MCA occlusion. The animals were killed after 24 hours of permanent MCA occlusion, and brains were stained with 2,3,5-triphenyltetrazolium chloride (TTC).
The TTC-derived, corrected infarct volume postmortem in the bFGF-treated group was significantly smaller than that in controls (126.6 +/- 51.9 versus 180.2 +/- 54.9 mm3, mean +/- SD, P = .038). Diffusion imaging showed essentially equal lesion volumes 3 hours after MCA occlusion (195.4 +/- 61 mm3 in the drug-treated group and 194.4 +/- 65 mm3 in controls). At 4 hours, ischemic lesion size was 182.1 +/- 56.9 mm3 in treated animals and 222.9 +/- 88.7 mm3 in the controls (P = .24, NS). Perfusion imaging did not show a change of cerebral perfusion within ischemic brain regions in the bFGF group during the infusion. No behavioral or physiological side effects were observed.
bFGF is a safe and effective treatment for focal cerebral ischemia in rats. We observed a modest delayed difference of ischemic lesion size in vivo with diffusion MRI. The diffusion-weighted MRI findings suggest a potential delayed therapeutic effect of bFGF, and the perfusion imaging findings imply that the effect is not due to increased blood flow to the ischemic region.
碱性成纤维细胞生长因子(bFGF)已被证明具有神经保护特性。本研究旨在评估在大鼠局灶性脑缺血诱导后30分钟给予bFGF对梗死体积的影响。在药物输注期间使用了扩散加权磁共振成像(MRI)和灌注MRI。
我们将20只Sprague-Dawley大鼠随机分为两组,一组接受药物治疗(n = 10),另一组接受溶剂对照(n = 10)。动物采用缝合模型进行大脑中动脉(MCA)闭塞。在缺血诱导后30分钟开始进行扩散加权MRI,并频繁重复3.5小时。在MCA闭塞后30分钟开始输注药物(每小时45微克/千克)或溶剂对照(生理盐水),并持续3小时。在MCA闭塞后25、90和150分钟进行灌注成像。在永久性MCA闭塞24小时后处死动物,并用2,3,5-三苯基氯化四氮唑(TTC)对大脑进行染色。
bFGF治疗组经TTC染色后校正的死后梗死体积明显小于对照组(126.6±51.9对180.2±54.9立方毫米,平均值±标准差,P = 0.038)。扩散成像显示MCA闭塞3小时后两组的病变体积基本相等(药物治疗组为195.4±61立方毫米,对照组为194.4±65立方毫米)。4小时时,治疗组的缺血性病变大小为182.1±56.9立方毫米,对照组为222.9±88.7立方毫米(P = 0.24,无统计学意义)。灌注成像未显示bFGF组在输注期间缺血脑区的脑灌注有变化。未观察到行为或生理方面的副作用。
bFGF是治疗大鼠局灶性脑缺血的一种安全有效的方法。我们通过扩散MRI在体内观察到缺血性病变大小存在适度的延迟差异。扩散加权MRI结果提示bFGF可能具有延迟治疗作用,灌注成像结果表明该作用并非由于缺血区域血流增加所致。